Stay updated on Frailty-guided Dosing in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.

Latest updates to the Frailty-guided Dosing in Myeloma Clinical Trial page
- Check7 days agoChange DetectedThe Record History now includes a new revision entry for v3.5.5 and removes the previous v3.5.4, updating the sequence of published revisions. This reflects an update to the page's revision tracking.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision tag v3.5.4 appears in the Record History, replacing the previous v3.5.3. This signals an updated version of the record history without detailing edits to the study data.SummaryDifference0.1%

- Check43 days agoChange DetectedThe Record History page now lists revision v3.5.3, replacing the previous v3.5.2. This indicates a minor update to the page's revision history.SummaryDifference0.1%

- Check57 days agoChange DetectedA new history entry, Revision: v3.5.2, was added. The older entry, Revision: v3.5.0, was removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Frailty-guided Dosing in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.